While mesothelioma cancer has been around for quite some time, doctors and research scientists have only just begun to receive the necessary funds to improve treatment options for the disease. In comparison with other cancers, mesothelioma is considered to be rare and research dollars have historically been sparse when it comes to allocating money for the study of asbestos-related disease.
Sources:
http://www.cancer.org/docroot/CRI/content/CRI_2_4_4X_Clinical_Trials_29.asp?sitearea=
http://www.cancer.gov/cancertopics/types/malignantmesothelioma
http://www.atsdr.cdc.gov/asbestos/medical_community/case_studies/
Dodson, R. and Hammar, S. Asbestos: Risk Assessment, Epidemiology, and Health Effects. Taylor & Francis: Boca Raton. 2006.
Parker, J. and Parker, P. Mesothelioma. ICON Health Publications: San Diego. 2004.
http://www.cancer.org/docroot/CRI/content/CRI_2_4_4X_Clinical_Trials_29.asp?sitearea=
http://www.cancer.gov/cancertopics/types/malignantmesothelioma
http://www.atsdr.cdc.gov/asbestos/medical_community/case_studies/
Dodson, R. and Hammar, S. Asbestos: Risk Assessment, Epidemiology, and Health Effects. Taylor & Francis: Boca Raton. 2006.
Parker, J. and Parker, P. Mesothelioma. ICON Health Publications: San Diego. 2004.
0 comments